Sphere

Sphere Equity Growth

The Year-over-Year Equity Growth of Sphere (347700.KQ) as of Oct 20, 2026 is 103.62 %. In the previous year, Year-over-Year Equity Growth was 248.19 % — a change of -58.25% (lower).

Equity Growth

103.62 %

YoY

-58.25%

Last updated:

Year-over-Year Equity Growth of Sphere is 2025 103.62 % . Year-over-Year Equity Growth of Sphere was 2024 248.19 % . It decreases by -58.25% lower compared to the previous year.

The Sphere Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2018
133.07 KRW
Jan 1, 2019
-680.83 KRW
Jan 1, 2020
161.96 KRW
Jan 1, 2021
497.39 KRW
Jan 1, 2022
-26.70 KRW
Jan 1, 2023
-6.23 KRW
Jan 1, 2024
248.19 KRW
Jan 1, 2025
103.62 KRW
The Sphere Equity Growth history
YEAREquity GrowthYoY
103.62 %-58.25%
248.19 %-4,085.74%
-6.23 %-76.68%
-26.70 %-105.37%
497.39 %+207.10%
161.96 %-123.79%
-680.83 %-611.62%
133.07 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sphere Stock analysis

What does Sphere do? Sphere Corp, listed under the ticker 347700.KQ and ISIN KR7347700007, is a South Korean health care company headquartered in Seoul. The company went public on March 23, 2021, and currently employs 53 full-time staff. Sphere Corp operates within the health care sector, focusing on digital health technology platforms and solutions. The company's website is https://lifesemantics.kr/, which serves as its primary online presence. Sphere Corp provides a digital health record data platform, enabling personalized health management through technology. The company's offerings include digital health technology platforms and digital health solutions, though specific product names such as LifeRecord, H.AI, OHA, Dr. Call, Redpill care, and Redpill breathtaking are not verified as part of the company's official portfolio. Additionally, Sphere Corp engages in the sale of diagnostic reagents and equipment, though details regarding these products are not elaborated in the provided information. The company's operations are based in Seoul, South Korea, and it is categorized under the health care industry. The information regarding its founding year, key personnel, and specific financial figures is not included in the provided data. Sphere Corp's focus remains on delivering digital health services through its platform, aiming to enhance personalized health care experiences for users. Sphere is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sphere stock

Year-over-Year Equity Growth of Sphere is 103.62 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Sphere since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Sphere historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Sphere

All Key Metrics — Sphere